Pylclari^®

Pylclari^®, a diagnostic F-18 tracer for the detection of prostate specific membrane antigen (PSMA), is a registered drug by Curium Pharma since 2024 and will be available for the Dutch market from 18 March onwards. BV Cyclotron VU will produce and deliver this tracer for Curium Pharma.

BV Cyclotron VU is proud to help saving lives of prostate cancer patients, because it is known that detection of early and/or metastatic prostate cancer will benefit overall survival of prostate cancer patients.